HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib.

Eric Wehrenberg-KleeNicoleta SineviciSarah NestiTaylor KalomerisEmily AustinBenjamin LarimerUmar Mahmood

Published in: Molecular imaging and biology (2021)

HER3 PET imaging can be used to visualize dynamic changes in HER3 expression that occur in HER2+ breast cancers with HER2 inhibitor treatment and identify those likely to benefit by the addition of combination HER3 and HER2 inhibition.

Keyphrases

pet imaging
positron emission tomography
poor prognosis
genome wide
computed tomography
young adults
replacement therapy